The economic impact of a bioterrorist attack: Are prevention and postattack intervention programs justifiable?

被引:245
作者
Kaufmann, AF [1 ]
Meltzer, MI [1 ]
Schmid, GP [1 ]
机构
[1] CTR DIS CONTROL & PREVENT, NATL CTR INFECT DIS, ATLANTA, GA 30333 USA
关键词
D O I
10.3201/eid0302.970201
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Understanding and quantifying the impact of a bioterrorist attack are essential in developing public health preparedness for such an attack. We constructed a model that compares the impact of three classic agents of biologic warfare (Bacillus anthracis, Brucella melitensis, and Francisella tularensis) when released as aerosols in the suburb of a major city. The model shows that the economic impact of a bioterrorist attack can range from an estimated $477.7 million per 100,000 persons exposed (brucellosis scenario) to $26.2 billion per 100,000 persons exposed (anthrax scenario). Rapid implementation of a postattack prophylaxis program is the single most important means of reducing these losses. By using an insurance analogy, our model provides economic justification for preparedness measures.
引用
收藏
页码:83 / 94
页数:12
相关论文
共 22 条
[1]   PATHOLOGY OF INHALATIONAL ANTHRAX IN 42 CASES FROM THE SVERDLOVSK OUTBREAK OF 1979 [J].
ABRAMOVA, FA ;
GRINBERG, LM ;
YAMPOLSKAYA, OV ;
WALKER, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (06) :2291-2294
[2]  
[Anonymous], [No title captured]
[3]  
Benenson AS., 1995, Control of communicable diseases manual. Control of communicable diseases manual, V16th
[4]  
CARDINALE V, 1996, 1996 DRUG TOPICS RED
[5]   The specter of biological weapons [J].
Cole, LA .
SCIENTIFIC AMERICAN, 1996, 275 (06) :60-65
[6]   POSTEXPOSURE PROPHYLAXIS AGAINST EXPERIMENTAL INHALATION ANTHRAX [J].
FRIEDLANDER, AM ;
WELKOS, SL ;
PITT, MLM ;
EZZELL, JW ;
WORSHAM, PL ;
ROSE, KJ ;
IVINS, BE ;
LOWE, JR ;
HOWE, GB ;
MIKESELL, P ;
LAWRENCE, WB .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (05) :1239-1243
[7]   AEROBIOLOGY [J].
GOCHENOUR, WS .
MILITARY MEDICINE, 1963, 128 (02) :86-&
[8]  
*HEALTHC CONS AM I, 1996, HEALTHC CONS 1996 PH
[9]  
KAUFMANN AF, 1980, ANN NY ACAD SCI, V335, P105
[10]  
LIPSCOMB J, 1966, COST EFFECTIVENESS H, P214